01
Orthobiology · Lund, Sweden
Moroxite AB
Synthetic bone replacement for spinal fusion. FDA Breakthrough Device Designation. Led by the founding team behind the Bonesupport exit.
Webinar · Co-hosted by Peter Moeller and the Moroxite CEO · 40 seats.
02
Metabolic Health · Sweden
SIGRID
Clinically validated OTC platform reducing the metabolic impact of modern meals. SHINE pivotal trial (n=318) published in eClinicalMedicine. First global oral health license signed.
Webinar · Hosted by Peter Moeller and the SIGRID CEO · 40 seats.
03
Munich-Süd · Off-market
Position II · Residential
A 90-unit residential block in a high-demographic-tailwind sub-market. Acquired below replacement cost. Co-invest open to qualified family offices.
04
DACH · Series A
Position III · B2B SaaS
European supply-chain optimization platform. Founders from a previously-acquired listed peer. Round closing imminent.